Aclaris Reuters for 7.79M shares and 6.5M warrants
Aclaris Therapeutics entered into an underwriting agreement to sell shares and pre-funded warrants for an aggregate of 14.29 million securities, priced and time-to-market details not provided in the document.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed